Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Carmen Galani"'
Autor:
Adam Gater, Diana Rofail, Chloe Tolley, Chris Marshall, Linda Abetz-Webb, Steven H. Zarit, Carmen Galani Berardo
Publikováno v:
Schizophrenia Research and Treatment, Vol 2014 (2014)
Objectives. As a disease typified by early onset and chronic disease course, caring for a person with schizophrenia may have a significant impact on caregivers’ lives. This study aimed to investigate the subjective experiences of caregivers of peop
Externí odkaz:
https://doaj.org/article/e664d3e3eca34298baee79cbb9ef8a22
Autor:
Rofail, Diana, Regnault, Antoine, le Scouiller, Stéphanie, Berardo, Carmen Galani, Umbricht, Daniel, Fitzpatrick, Ray
Publikováno v:
Quality of Life Research, 2016 Jan 01. 25(1), 201-211.
Externí odkaz:
https://www.jstor.org/stable/44849707
Autor:
Schooler, Nina R., Buchanan, Robert W., Laughren, Thomas, Leucht, Stefan, Nasrallah, Henry A., Potkin, Steven G., Abi-Saab, Danielle, Berardo, Carmen Galani, Bugarski-Kirola, Dragana, Blaettler, Thomas, Edgar, Chris J., Nordstroem, Anna-Lena, O'Gorman, Cedric, Garibaldi, George
Publikováno v:
In Schizophrenia Research March 2015 162(1-3):169-174
Publikováno v:
In Schizophrenia Research November 2013 150(2-3):339-342
Autor:
Antoine Regnault, Diana Rofail, Daniel Umbricht, Stephanie Le Scouiller, Carmen Galani Berardo, Ray Fitzpatrick
Publikováno v:
Quality of Life Research. 25:201-211
Symptoms of schizophrenia fall into three categories (positive, negative and cognitive symptoms), which probably impact differently on patient’s health-related quality of life (HRQoL). The present study aimed to explore HRQoL in patients with promi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2a2ea3e63e8c7499b2644193dd8e50e
https://doi.org/10.1007/s11136-015-1057-9
https://doi.org/10.1007/s11136-015-1057-9
Autor:
Justine K. Lalonde, Carmen Galani Berardo, Anna-Lena Nordstroem, Darren Talbot, Corrado Bernasconi
Publikováno v:
The International journal of social psychiatry. 63(2)
Background: Few studies have examined the impact of persistent symptoms of schizophrenia, especially with respect to patient-reported outcomes (PROs), carer burden and health economic impact. Aims: Analyse data relating to burden and severity of illn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8162ae1ce961d08b36e75d4143544f70
https://pubmed.ncbi.nlm.nih.gov/28134026
https://pubmed.ncbi.nlm.nih.gov/28134026
Autor:
Thor-Henrik Brodtkorb, Birgitta von Scheele, Carmen Galani Berardo, Anita Patel, Claire Ainsworth, Josephine Mauskopf
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 14:235-257
Complex modeling techniques such as discrete-event simulation and simpler Markov or decision-tree models have been used to estimate the cost-effectiveness of treatment for chronic diseases such as schizophrenia. A systematic literature review of MEDL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::300e4458699640cf9e2ba8b526edab45
https://doi.org/10.1586/14737167.2014.891443
https://doi.org/10.1586/14737167.2014.891443
Autor:
Carmen Galani Berardo, Linda Abetz-Webb, Diana Rofail, Chris Marshall, Steven H. Zarit, Chloe Tolley, Adam Gater
Publikováno v:
Schizophrenia Research and Treatment, Vol 2014 (2014)
Schizophrenia Research and Treatment
Schizophrenia Research and Treatment
Objectives. As a disease typified by early onset and chronic disease course, caring for a person with schizophrenia may have a significant impact on caregivers’ lives. This study aimed to investigate the subjective experiences of caregivers of peop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::769bd4877027e2cb495c64ca35f5e0fa
https://doi.org/10.1155/2014/368215
https://doi.org/10.1155/2014/368215
Autor:
David R. Gandara, Chaienna Morel, Claire Watkins, Christian Schulz, Marcus Ballinger, Paula Chu, Carmen Galani Berardo, Jason Foo, Rachel Rosenthal
Publikováno v:
Clinical Lung Cancer. 20:451-460.e5
Background Extended onset of treatment effect and longer-term survival with anti–programmed death-ligand 1 (PD-L1)/programmed cell death protein 1 (PD-1) immunotherapies, atezolizumab, nivolumab, and pembrolizumab, have changed the landscape of sec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8df467749dec1cc095d5f3f3e0ba4838
https://doi.org/10.1016/j.cllc.2019.06.017
https://doi.org/10.1016/j.cllc.2019.06.017
Autor:
Marcus Ballinger, C. Morel, C. Watkins, Carmen Galani Berardo, B. Karthuria, J. Foo, P. Chu, Christian Schulz, David R. Gandara
Publikováno v:
Annals of Oncology. 29:viii532-viii533
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f02fdeb5190785348fe926515633716f
https://doi.org/10.1093/annonc/mdy292.092
https://doi.org/10.1093/annonc/mdy292.092